| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 128,545 | 129,185 | 136,323 | 159,311 | | Cost of Revenue | 82,339 | 84,630 | 88,308 | 101,557 | | | Gross Profit | 46,206 | 44,555 | 48,015 | 57,754 | | | Operating Expenses | | Research Development | 1,523 | 1,680 | 1,407 | 1,426 | | Selling General and Administrative | 26,185 | 31,052 | 30,187 | 34,601 | | Non Recurring | 11,453 | 3,529 | 4,611 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,397 | 8,294 | 11,810 | 21,727 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,397 | 8,294 | 11,810 | 21,727 | | Interest Expense | 1,834 | 1,786 | 1,846 | 2,138 | | Income Before Tax | 7,563 | 6,508 | 9,964 | 19,589 | | Income Tax Expense | 2,188 | 2,142 | 3,103 | 9,210 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,375 | 4,366 | 6,861 | 10,379 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,375 | 4,366 | 6,861 | 10,379 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (3,492) | | | Net Income Applicable To Common Shares | $5,375 | $4,366 | $6,861 | $6,887 |
|
0.51% Nasdaq 0.00%
Income Statement
